Lung cancer begins in the lungs and has become the leading cause of cancer deaths in the United States for both men and women--claiming more lives than colon, ovarian, prostate, and breast cancer combined. There are two types of lung cancer: small and non-small based on the appearance of the cancer cells on the microscope. Non-small cell lung cancer accounts for approximately 85% of lung cancers and include squamous cell carcinoma, adenocarcinoma, and large cell carcinoma. Risk for being diagnosed with lung cancer includes smoking, second hand smoke, exposure to radon gas, asbestos, and other chemicals, excessive alcohol use, and a family history. Treatments depend on the stage as well as type of lung cancer but include: surgery, chemotherapy, radiation, targeted drug therapy, and clinical trials. Stage III can be divided into parts IIIA and IIIB. In stage IIIB, diagnosis depends on the size and location of the tumor as well as if lymph nodes have been infected. One scenario is that cancer has spread to the lymph nodes above the collarbone or to the lymph nodes on the opposite side of the chest as the tumor. The cancer may have spread around the chest cavity, multiple tumors in the same lobe may be present, the lung may suffer from pneumonitis, and the tumor may be any size. Another scenario is that the cancer has not spread to the lymph nodes but has spread to locations such as the heart, esophagus, carina, sternum, trachea, or blood vessels that lead to or from the heart.
Stage Iiib Non-small Cell Lung Cancer Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Stage Iiib Non-small Cell Lung Cancer below!
For more information on how to use Laverne, please read the How to Guide.
We have 1076 products for the study of Stage Iiib Non-small Cell Lung Cancer that can be applied to Flow Cytometry, Western Blot, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.